Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-mechanical heart valve surgery warfarin management study
ACTRN12613000818730Phase 4Withdrawn
- Sponsor
- Flinders Medical Centre
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of warfarin in status post mechanical heart valve replacement (2 arms), sponsored by Flinders Medical Centre. Primary endpoint: Time to achieve an initial stable therapeutic INR. Planned start Aug 2013; status: withdrawn.
02
Drugs
warfarin
03
Conditions
status post mechanical heart valve replacement
Beyond the preview
Go deeper on ACTRN12613000818730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000818730.